Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358276 · ClinicalTrials.gov registry record · NA
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
A NA study of Skin Carcinoma, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 840
- Enrollment target
- 1
- Study location
NCT04358276: Active NA study of Skin Carcinoma, sponsored by City of Hope Medical Center.
NCT04358276 is a NA study of Skin Carcinoma that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 840 participants, above the 79-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (963% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04358276, a NA study of Skin Carcinoma, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. Many of these complications may not be known for years after the treatment and preventive measures can be taken to reduce the chances that a complication will occur and encourage early detection. This study focuses on one complication that stem cell transplant survivors are at high risk of developing - skin cancer. An early diagnosis of skin cancer is important since the cancer is usually smaller, requires less extensive treatments, and has better outcomes. Teaching skin self-examination and encouraging patients to alert doctors to skin changes may provide an important opportunity for early detection of skin cancer.
Primary Outcome
Will administer questionnaires at baseline and 12 months to ask about skin examinations performed within the past 12 months. Will use logistic regression to adjust for imbalance in patient characteristics and risk factors. Will also test for group by covariate interactions, depending on group main effect.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Educational Intervention
- OTHER Computer-Assisted Intervention
- DEVICE Dermatoscope
- OTHER Educational Intervention (Physician)
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT04358276 still lists
NCT04358276 is an interventional study that assigns participants to a tested intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, above the 79-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (963% higher).
The record links to 1 condition, with Skin Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT04358276 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04358276 about?
NCT04358276 is a clinical study titled "Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study". This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. ...
What is the current status of trial NCT04358276?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 840 participants. The study started on 2020-10-30. Estimated completion is 2026-03-31.
What conditions does trial NCT04358276 study?
This clinical trial studies the following conditions: Skin Carcinoma.
What interventions are being tested in trial NCT04358276?
The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER), Computer-Assisted Intervention (OTHER), Dermatoscope (DEVICE), Educational Intervention (Physician) (OTHER).
Who is sponsoring clinical trial NCT04358276?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04358276 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
ACTIVE NOT RECRUITING · NA
-
SMART Project in Preventing Skin Cancer
COMPLETED · NA
-
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
COMPLETED · NA
-
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI